FR2381525B1 - - Google Patents
Info
- Publication number
- FR2381525B1 FR2381525B1 FR7805566A FR7805566A FR2381525B1 FR 2381525 B1 FR2381525 B1 FR 2381525B1 FR 7805566 A FR7805566 A FR 7805566A FR 7805566 A FR7805566 A FR 7805566A FR 2381525 B1 FR2381525 B1 FR 2381525B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8273/77A GB1560274A (en) | 1977-02-28 | 1977-02-28 | Phenylbut 1-ene derivatives having antiostrogenicactivity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2381525A1 FR2381525A1 (fr) | 1978-09-22 |
| FR2381525B1 true FR2381525B1 (enExample) | 1980-08-29 |
Family
ID=9849341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7805566A Granted FR2381525A1 (fr) | 1977-02-28 | 1978-02-27 | Compositions pharmaceutiques antioestrogenes |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4198435A (enExample) |
| JP (1) | JPS53107425A (enExample) |
| AU (1) | AU515458B2 (enExample) |
| BE (1) | BE864359A (enExample) |
| DE (1) | DE2807599C2 (enExample) |
| FR (1) | FR2381525A1 (enExample) |
| GB (1) | GB1560274A (enExample) |
| NL (1) | NL7801739A (enExample) |
| NZ (1) | NZ186403A (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE637389A (enExample) * | 1962-09-13 | |||
| US4206234A (en) * | 1977-08-22 | 1980-06-03 | Imperial Chemical Industries Limited | Triphenylbut-1-ene derivatives and pharmaceutical compositions and uses thereof |
| ATE2423T1 (de) * | 1978-11-07 | 1983-03-15 | Imperial Chemical Industries Plc | 1-acyloxyphenyl-1,2-diphenylalken-derivate, verfahren zu deren herstellung und eine diese derivate enthaltende pharmazeutische zusammensetzung. |
| DE3046719C2 (de) * | 1980-12-11 | 1983-02-17 | Klinge Pharma GmbH, 8000 München | 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
| CA1289570C (en) * | 1986-06-16 | 1991-09-24 | Tetsuji Asao | 1,1,2-triaryl-1-alkene derivatives |
| EP0287690B1 (de) * | 1987-04-21 | 1992-09-02 | HEUMANN PHARMA GMBH & CO | Stabile Lösungsmitteladdukte von Z-1-(p-beta-Dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-en |
| US5204337A (en) * | 1988-10-31 | 1993-04-20 | Endorecherche Inc. | Estrogen nucleus derivatives for use in inhibition of sex steroid activity |
| ZA924811B (en) * | 1991-06-28 | 1993-12-29 | Endorecherche Inc | Controlled release systems and low dose androgens |
| DE4320896A1 (de) * | 1993-06-24 | 1995-01-05 | Denecke Rainer Dr Med Vet | Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen |
| DE4407742C1 (de) * | 1994-03-08 | 1995-06-22 | Hexal Pharma Gmbh | Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat |
| US5681835A (en) * | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
| ATE232743T1 (de) * | 1994-06-27 | 2003-03-15 | Neutron Therapies Inc | Bor enthaltende hormonanaloga und verfahren fuer ihre verwendung zur bildlichen darstellung oder zum abtoeten von zellen, die hormonrezeptoren besitzen |
| ATE411016T1 (de) | 1997-08-15 | 2008-10-15 | Univ Duke | Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten |
| US6245352B1 (en) * | 1999-04-27 | 2001-06-12 | Eli Lilly And Company | Pharmaceutical formulation |
| ATE301129T1 (de) | 1999-05-04 | 2005-08-15 | Strakan Int Ltd | Androgen glykoside und die androgenische aktivität davon |
| US20030032676A1 (en) * | 2001-08-09 | 2003-02-13 | Kimelberg Harold K. | Drugs for treatment of cerebral injury and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE637389A (enExample) * | 1962-09-13 |
-
1977
- 1977-02-28 GB GB8273/77A patent/GB1560274A/en not_active Expired
-
1978
- 1978-02-02 US US05/874,481 patent/US4198435A/en not_active Expired - Lifetime
- 1978-02-07 NZ NZ186403A patent/NZ186403A/xx unknown
- 1978-02-10 AU AU33190/78A patent/AU515458B2/en not_active Expired
- 1978-02-16 NL NL7801739A patent/NL7801739A/xx not_active Application Discontinuation
- 1978-02-22 DE DE2807599A patent/DE2807599C2/de not_active Expired
- 1978-02-27 BE BE185518A patent/BE864359A/xx not_active IP Right Cessation
- 1978-02-27 JP JP2196578A patent/JPS53107425A/ja active Granted
- 1978-02-27 FR FR7805566A patent/FR2381525A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| AU515458B2 (en) | 1981-04-02 |
| AU3319078A (en) | 1979-08-16 |
| NZ186403A (en) | 1984-08-24 |
| FR2381525A1 (fr) | 1978-09-22 |
| JPS53107425A (en) | 1978-09-19 |
| BE864359A (fr) | 1978-08-28 |
| NL7801739A (nl) | 1978-08-30 |
| DE2807599A1 (de) | 1978-08-31 |
| DE2807599C2 (de) | 1987-04-09 |
| US4198435A (en) | 1980-04-15 |
| GB1560274A (en) | 1980-02-06 |
| JPS6339567B2 (enExample) | 1988-08-05 |